Clinical Trials | AdventHealth Research Institute

Showing 1 - 2 of 2 clinical trials matching your search

NCT05506943

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen

This study is currently enrolling.

Associated Conditions: Biliary Tract Cancer

Research Area: Cancer Research

Research Location: Orlando, Florida
NCT06282575

An open-label randomized trial of the efficacy and safety of zanidatamab with standard-of-care therapy against standard-of-care therapy alone for advanced HER2-positive biliary tract cancer

This study is currently enrolling.

Associated Conditions: Liver Cancer

Research Area: Cancer Research

Research Location: Orlando, Florida

This is an open-label, randomized, multicenter, phase 3 study to investigate the efficacy and safety of zanidatamab plus CisGem with or without a PD-1/L1 inhibitor (physician’s choice of either...